top of page

2025 Legislative Priorities

Tracking Kidney Care Priorities in Oregon & Washington

​

The Washington Legislature runs through April 2025, and Oregon legislators will be in session until June 2025. Stay updated on key bills affecting kidney patients, dialysis providers, and the broader healthcare community. 

​

Below, you'll find real-time updates on legislation, where each bill is in the process, and how you can help support.

Washington State Legislation Priority Legislation

WA Priorities

By legislative rules, legislation noted as “inactive” means that it is “dead” for the remainder of the 2025 session. However, legislation noted as “inactive” in 2025 will be automatically considered “alive” in 2026 because it’s the second year of the biennium.

Position: Support

​​​

Thank you, sponsors: Reps. Low, Davis

​​​

Status: Inactive. This legislation is inactive because of the cost of implementing.

​​​

Read our testimony: Submitted 1/20

Position: Support

 

Thank you, sponsors: Reps. Santos, Thai, Doglio, Berry, Ryu, Obras, Ormsby, Scott, Parshley, Timmons, Pollet, Macri, Simmons, Hunt, Hill

 

Status: Inactive. his legislation is inactive due to a lack of consensus.

​

Testimony: Submitted 1/24

Position: Support

 

Thank you, sponsors: Reps. Thai, Ormsby, Salahuddin, Parshley, Taylor, Hill, Doglio, Pollet, Nance, Callan, Fosse

 

Status: Inactive. This legislation is inactive due to cost implications. However, there is funding in both the Senate and House versions of the budget for the Office of the Insurance Commissioner to analyze the cost of implementing an obesity treatment benefit in consultation with the Health Care Authority.

Position: Support

​

Thank you, sponsors: Reps. Lekanoff, Macri

​

Status: Inactive. While HB 1379 is inactive, its Senate companion legislation, SB 5084, has passed both the House and the Senate, and it’s on the Governor’s desk awaiting his signature.

​

Testimony: Submitted 1/23

Position: Support

 

Thank you, sponsors: Reps. Macri, Leavitt, Simmons, Davis, Berry, Ryu, Callan, Rule, Stearns, Peterson, Taylor, Reed, Ramel, Alvarado, Doglio, Tharinger, Fey, Salahuddin, Bernbaum, Fosse, Pollet, Street, Scott, Santos

 

Status: Active. This legislation is still active. It passed the House and is scheduled for a hearing in Senate Ways & Means on April 3, and for an executive session on April 7.

Position: Support

 

Thank you, sponsors: Reps. Berg, Rude, Leavitt, Stonier, Simmons, Davis, Berry, Mena, Stearns, Thai, Walen, Rule, Ryu, Parshley, Peterson, Reed, Paul, Gregerson, Alvarado, Reeves, Goodman, Cortes, Obras, Fey, Salahuddin, Springer, Bernbaum, Fosse, Pollet, Street, Hill, Macri, Timmons, Scott

 

Status: Inactive. This legislation is inactive due to the cost of implementation and the fact that it’s not mentioned in the House budget proposal.

 

Testimony: Submitted 1/31

Position: Support

 

Thank you, sponsors: Reps. Berg, Parshley, Reed, Bernbaum, Thai, Kloba, Hill

 

Status: : Inactive. This legislation is inactive due to concerns expressed by the Office of the Insurance Commissioner as well as health care insurers about the potential for increased cost of Medigap insurance if the legislation were to be enacted.

Position: Support

 

Thank you, sponsors: Reps. Thai, Parshley, Pollet

 

Status: Inactive. This legislation is inactive due to concerns expressed by the Office of the Insurance Commissioner as well as health care insurers about the potential for increased cost of medigap insurance if the legislation were to be enacted.

Position: Support

​​​

Thank you, sponsors: Sens. Liias, Holy, Stanford, Wagoner, Lovick, Gildon, Cleveland, Cortes, Fortunato, Harris, Nobles, Riccelli, Warnick

​​​

Status: Inactive. This legislation is inactive because of the cost of implementing.

​​​​

Read our testimony: Submitted 1/20

Position: Support

​

Thank you, sponsors: Sens. Robinson, Muzzall, Dhingra, Hasegawa, Krishnadasan, Nobles, Salomon

​

Status: Active. This legislation passed both the House and the Senate and will be signed into law by the Governor on April 4.

Position: Support

 

Thank you, sponsors: Sens. Riccelli, Hasegawa, Conway, Nobles, Wilson, C.

 

Status: Inactive. This legislation is inactive due to a lack of consensus.

 

Testimony: Submitted 1/24

Position: Support

 

Thank you, sponsors: Sens. Cleveland, Muzzall, Chapman, Hasegawa, Krishnadasan, Nobles, Trudeau, Valdez

​

Status: Inactive. This legislation is inactive due to the cost of implementing.

 

Testimony: Submitted 1/24

Position: Support

 

Thank you, sponsors: Requested by Governor; Sens. Riccelli, Nobles, Harris, Cortes, Slatter, Orwall, Chapman, Ramos, Trudeau, Kauffman, Muzzall, Lovelett, Valdez, Krishnadasan, Hasegawa, Lovick, Liias, Saldaña, Dhingra, Conway, Bateman, Holy, Christian, Cleveland, King, Frame, Salomon, Stanford, Wilson, C.

 

Status: Inactive. This legislation is inactive due to the cost of implementation and the fact that it’s not mentioned in the Senate budget proposal.

 

Testimony: Submitted 1/31

Position: Support

 

Thank you, sponsors: Sens. Cleveland, Muzzall, Riccelli, Bateman, Frame, Hasegawa, Krishnadasan, Nobles, Valdez, Wilson, C.

 

Status: Inactive. This legislation is inactive due to cost implications. However, there is funding in both the Senate and House versions of the budget for the Office of the Insurance Commissioner to analyze the cost of implementing an obesity treatment benefit in consultation with the Health Care Authority.

​

Testimony: Submitted 1/31

Position: Support

 

Thank you, sponsors: Sens. Riccelli, Harris, Bateman, Liias, Nobles, Valdez

 

Status:  Inactive. This legislation is probably inactive, but its companion, HB 1392, is progressing.

Position: Support

 

Thank you, sponsors: Sens. Orwall, Muzzall, Hasegawa, Lovelett, Nobles, Slatter

 

Status: Inactive. This legislation was not scheduled for a vote in Ways & Means due to the high cost of implementation.

Position: Support

 

Thank you, sponsors: Sens. Cleveland, Muzzall, Shewmake

 

Status: Inactive. This legislation failed to progress because the Department of Health and the Department of Social and Health Services wanted more time to review the policy implications.

Oregon Legislation Priority Legislation

Oregon Priorities

Position: Support
​​​
Thank you, sponsors: Sen. Smith DB
​​​
Status: This bill will not move forward this session.
​​​​
Read our testimony: TBD

Position: Support

​​​

Thank you, sponsors: Sen. Campos

​​​

Status: See the latest

​​​​

Read our testimony: Submitted 3/19

Position: Support

​​​

Thank you, sponsors: Reps Pham, H., Javadi, McIntire

​​​

Status: See the latest​​​​

​

Testimony: See patient group letter

Position: Support

​​​

Thank you, sponsors: Rep. Diehl

​​​

Status: See the latest

​​​​

Read our testimony: Submitted 02/13.

Position: Support

​​​

Thank you, sponsors: Rep. Tran

​​​

Status: See the latest

​​​​

Read our testimony: Submitted 03/03.

Position: Support
​​​
Thank you, sponsors: Reps. Neron, Pham H, Javadi, Bowman, Munoz, Owens, Sen. Reynolds
​​​
Status: See the latest

Position: Support
​​​
Thank you, sponsors: Rep. Tran
​​​
Status: This bill will not move forward this session.

Now Take the Next Step

Engaging in the legislative process is easier than ever, with virtual testimony options and opportunities to contact lawmakers directly. Your voice can make a real impact.

 

  1. Submit Testimony – Click the bill links above to share your voice with lawmakers. You can feel free to use the points included in our testimony!
     

  2. Thank Your Legislators – Reach out to sponsors and express appreciation for their leadership. Let us know if you need help finding their contact information — they would love to hear from you.
     

  3. Stay Updated – Follow us on social media and sign up for our newsletter.

bottom of page